» Articles » PMID: 31806004

Wharton's Jelly Mesenchymal Stem Cell-based or Umbilical Vein Endothelial Cell-based Serum-free Coculture with Cytokines Supports the Ex Vivo Expansion/maintenance of Cord Blood Hematopoietic Stem/progenitor Cells

Overview
Publisher Biomed Central
Date 2019 Dec 7
PMID 31806004
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The umbilical cord blood (UCB) has been widely accepted as an alternative source of hematopoietic stem/progenitor cells (HSPCs) for transplantation, and its use in adults is still restricted because of low absolute numbers. To overcome this obstacle, expansion of UCB-HSPCs under feeder cell-based coculture is a promising possibility. In this study, we explored UCB-CD34+ cells ex vivo expansion using Wharton's jelly mesenchymal stem cells (WJ-MSCs) or umbilical vein endothelial cells (UVECs) as feeder layer-based serum-free coculture system with a cocktail of cytokines.

Methods: UCB-CD34+ cells were cultured in five different coculture conditions composed of umbilical cord stromal cells (WJ-MSCs or UVECs) with or without a cocktail of cytokines (SCF, FLT3L, and TPO). The cultured cells were harvested at day 10 and analyzed for phenotypes and functionalities, including total nuclear cells (TNCs), CD34+ cells, CD34+CD38- cells, colony-forming unit (CFU) for committed progenitors, and long-term culture initiating cells (LTC-ICs) for HSPCs.

Results: Our work showed the numbers of TNC cells, CD34+ cells, and CD34+CD38- cells were expanded under five coculture conditions, and the feeder layer-based cocultures further promoted the expansion. The numbers of colonies of CFU-GM, CFU-E/BFU-E, and CFU-GEMM in the cocultures with cytokines were significantly higher than their counterparts at day 0 (p < 0.05), while no significant difference (p > 0.05) in those without the addition of cytokines. The numbers of LTC-ICs were increased both under the WJ-MSCs and UVECs with cytokine cocultures, but only in the UVECs group showed a significant difference (p < 0.05), and were decreased under conditions without cytokine (p < 0.05).

Conclusion: Our data demonstrate that both WJ-MSCs and UVECs as feeder layer could efficiently support the expansion of UCB-CD34+ cells in synergy with SCF, FLT3L, and TPO under serum-free culture condition. The UVECs combined with the 3GF cytokine cocktail could maintain the growth of LTC-ICs derived from UCB-CD34+ cells and even expand to some extent.

Citing Articles

CH02 peptide promotes expansion of umbilical cord blood-derived CD34 hematopoietic stem/progenitor cells.

Yang Y, Zhang B, Xie J, Li J, Liu J, Liu R Acta Biochim Biophys Sin (Shanghai). 2023; 55(10):1630-1639.

PMID: 37381672 PMC: 10577473. DOI: 10.3724/abbs.2023047.


Recent advances in engineering hydrogels for niche biomimicking and hematopoietic stem cell culturing.

Huang X, Wang Y, Wang T, Wen F, Liu S, Oudeng G Front Bioeng Biotechnol. 2022; 10:1049965.

PMID: 36507253 PMC: 9730123. DOI: 10.3389/fbioe.2022.1049965.


Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs.

Yao G, Qi J, Li X, Tang X, Li W, Chen W Stem Cell Res Ther. 2022; 13(1):328.

PMID: 35850768 PMC: 9290280. DOI: 10.1186/s13287-022-03002-y.


DNA barcode to trace the development and differentiation of cord blood stem cells (Review).

Wang M, Zhou Y, Lai G, Huang Q, Cai W, Han Z Mol Med Rep. 2021; 24(6).

PMID: 34643250 PMC: 8524429. DOI: 10.3892/mmr.2021.12489.


Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34-enriched cells.

Bucar S, Branco A, Mata M, Milhano J, Caramalho I, Cabral J Stem Cell Res Ther. 2021; 12(1):399.

PMID: 34256848 PMC: 8278708. DOI: 10.1186/s13287-021-02474-8.


References
1.
Magin A, Korfer N, Partenheimer H, Lange C, Zander A, Noll T . Primary cells as feeder cells for coculture expansion of human hematopoietic stem cells from umbilical cord blood--a comparative study. Stem Cells Dev. 2008; 18(1):173-86. DOI: 10.1089/scd.2007.0273. View

2.
Fajardo-Orduna G, Mayani H, Flores-Guzman P, Flores-Figueroa E, Hernandez-Estevez E, Castro-Manrreza M . Human Mesenchymal Stem/Stromal Cells from Umbilical Cord Blood and Placenta Exhibit Similar Capacities to Promote Expansion of Hematopoietic Progenitor Cells In Vitro. Stem Cells Int. 2018; 2017:6061729. PMC: 5840651. DOI: 10.1155/2017/6061729. View

3.
Traycoff C, Abboud M, Laver J, Clapp D, Srour E . Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential. Exp Hematol. 1994; 22(13):1264-72. View

4.
Encabo A, Mateu E, Carbonell-Uberos F, Minana M . CD34+CD38- is a good predictive marker of cloning ability and expansion potential of CD34+ cord blood cells. Transfusion. 2003; 43(3):383-9. DOI: 10.1046/j.1537-2995.2003.00338.x. View

5.
Yamaguchi M, Hirayama F, Kanai M, Sato N, Fukazawa K, Yamashita K . Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells. Exp Hematol. 2001; 29(2):174-82. DOI: 10.1016/s0301-472x(00)00653-6. View